AI diagnostic opportunity assessment

Less than 1 min read

Scroll

The challenge

One of our pharma clients was evaluating an investment into several AI and biomarker diagnostic solutions that could improve overall diagnosis rates for a rare disease.

Our solution

We evaluated the client knowledge base of the disease area and patient journey across real-world data (RWD) and primary market insights. Our experts organized these insights within an opportunity assessment framework and identified key knowledge gaps. We also conducted qualitative HCP research to complete the assessment.

The results

We developed strategic recommendations for our client around the opportunity assessment of these AI diagnostic technologies, which enabled the client to push forward with further investment.

Insights

More insights.

See all insights

AI algorithm landscape assessment

Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.

Use of Gen AI to create Plain Language Summaries (PLS)

Putnam established technical feasibility for use of Gen AI to create Plain Language Summaries (PLS).

The Value of AI, The Value of People: Perspectives from Putnam’s CEO

Remco op den Kelder, Putnam CEO, shares how the firm is using AI to enable teams in solving client challenges.

Centers of Excellence

AI at Putnam

Open roles